Sanofi asthma drug shows positive midstage results, Citi says more trials needed
Citi says Sanofi’s midstage asthma-drug results look positive, but additional data is needed to determine whether the medicine is differentiated versus a rival treatment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.